Insulin Delivery Devices Market Statistics & Trends, 2024-2032

Insulin Delivery Devices Market Size – By Product (Insulin Pumps, Insulin Pens, Insulin Pen Needles, Insulin Jet Injectors, Insulin Syringes), By End-use & Global Forecast, 2024 – 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Industry coverage

1.2&nbsp;&nbsp;&nbsp; Market scope &amp; definitions

1.3&nbsp;&nbsp;&nbsp; Base estimates &amp; working

1.3.1&nbsp;&nbsp;&nbsp; Data collection

1.4&nbsp;&nbsp;&nbsp; Forecast parameters

1.5&nbsp;&nbsp;&nbsp; COVID-19 impact at global level

1.6&nbsp;&nbsp;&nbsp; Data validation

1.7&nbsp;&nbsp;&nbsp; Data sources

1.7.1&nbsp;&nbsp;&nbsp; Primary

1.7.2&nbsp;&nbsp;&nbsp; Secondary

1.7.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.7.2.2&nbsp;&nbsp;&nbsp;Unpaid sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Insulin delivery devices industry 360&ordm; synopsis, 2018 &ndash; 2032

2.2&nbsp;&nbsp;&nbsp; Business trends

2.3&nbsp;&nbsp;&nbsp; Regional trends

2.4&nbsp;&nbsp;&nbsp; Product trends

2.5&nbsp;&nbsp;&nbsp; End-use trends

Chapter 3&nbsp;&nbsp;&nbsp;Insulin Delivery Devices Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp;Rising prevalence of diabetes

3.2.1.2&nbsp;&nbsp;&nbsp;Technological advancements in insulin delivery devices

3.2.1.3&nbsp;&nbsp;&nbsp;Increasing diabetes care expenditure

3.2.1.4&nbsp;&nbsp;&nbsp;Favourable device insurance and reimbursement policies

3.2.1.5&nbsp;&nbsp;&nbsp;Adoption of facilitative initiatives

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp;High cost of insulin pumps

3.2.2.2&nbsp;&nbsp;&nbsp;High out-of-pocket expenditure in developing countries

3.2.2.3&nbsp;&nbsp;&nbsp;Stringent government regulations

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.3.1&nbsp;&nbsp;&nbsp; By product

3.3.2&nbsp;&nbsp;&nbsp; By end-use

3.4&nbsp;&nbsp;&nbsp; COVID- 19 impact analysis

3.5&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5.1&nbsp;&nbsp;&nbsp; U.S.

3.5.2&nbsp;&nbsp;&nbsp; Europe

3.6&nbsp;&nbsp;&nbsp; Reimbursement scenario

3.7&nbsp;&nbsp;&nbsp; Technology landscape

3.8&nbsp;&nbsp;&nbsp; Future market trends

3.9&nbsp;&nbsp;&nbsp; Gap analysis

3.10&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.11&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2022

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis, 2022

4.3&nbsp;&nbsp;&nbsp; Company market share analysis, 2022

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.5&nbsp;&nbsp;&nbsp; Vendor matrix analysis, 2022

4.6&nbsp;&nbsp;&nbsp; Strategy dashboard, 2022

Chapter 5&nbsp;&nbsp;&nbsp;Insulin Delivery Devices Market Size and Forecast, By Product (USD Million)

5.1&nbsp;&nbsp;&nbsp; Key trends, by product

5.2&nbsp;&nbsp;&nbsp; Insulin Pumps

5.2.1&nbsp;&nbsp;&nbsp; Tubed/tethered

5.2.2&nbsp;&nbsp;&nbsp; Tubeless

5.3&nbsp;&nbsp;&nbsp; Insulin Pens

5.3.1&nbsp;&nbsp;&nbsp; Reusable

5.3.2&nbsp;&nbsp;&nbsp; Disposable

5.4&nbsp;&nbsp;&nbsp; Insulin Pen needles

5.4.1&nbsp;&nbsp;&nbsp; Safety

5.4.2&nbsp;&nbsp;&nbsp; Standard

5.5&nbsp;&nbsp;&nbsp; Insulin Jet injectors

5.6&nbsp;&nbsp;&nbsp; Insulin Syringes

5.7&nbsp;&nbsp;&nbsp; Others

Chapter 6&nbsp;&nbsp;&nbsp;Insulin Delivery Devices Market Size and Forecast, By End-use (USD Million)

6.1&nbsp;&nbsp;&nbsp; Key trends, by end-use

6.2&nbsp;&nbsp;&nbsp; Home care

6.3&nbsp;&nbsp;&nbsp; Hospitals &amp; clinics

6.4&nbsp;&nbsp;&nbsp; Others

Chapter 7&nbsp;&nbsp;&nbsp;Insulin Clearance Devices Market Size and Forecast, By Region (USD Million)

7.1&nbsp;&nbsp;&nbsp; Key trends, by region

7.2&nbsp;&nbsp;&nbsp; North America

7.2.1&nbsp;&nbsp;&nbsp; U.S.

7.2.2&nbsp;&nbsp;&nbsp; Canada

7.3&nbsp;&nbsp;&nbsp; Europe

7.3.1&nbsp;&nbsp;&nbsp; Germany

7.3.2&nbsp;&nbsp;&nbsp; UK

7.3.3&nbsp;&nbsp;&nbsp; France

7.3.4&nbsp;&nbsp;&nbsp; Spain

7.3.5&nbsp;&nbsp;&nbsp; Italy

7.4&nbsp;&nbsp;&nbsp; Asia Pacific

7.4.1&nbsp;&nbsp;&nbsp; Japan

7.4.2&nbsp;&nbsp;&nbsp; China

7.4.3&nbsp;&nbsp;&nbsp; India

7.4.4&nbsp;&nbsp;&nbsp; Australia

7.4.5&nbsp;&nbsp;&nbsp; South Korea

7.5&nbsp;&nbsp;&nbsp; Latin America

7.5.1&nbsp;&nbsp;&nbsp; Brazil

7.5.2&nbsp;&nbsp;&nbsp; Mexico

7.5.3&nbsp;&nbsp;&nbsp; Argentina

7.6&nbsp;&nbsp;&nbsp; MEA

7.6.1&nbsp;&nbsp;&nbsp; South Africa

7.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

7.6.3&nbsp;&nbsp;&nbsp; Egypt

Chapter 8&nbsp;&nbsp;&nbsp;Company Profiles

8.1&nbsp;&nbsp;&nbsp; Novo Nordisk A/S

8.2&nbsp;&nbsp;&nbsp; Ypsomed Holdings AG

8.3&nbsp;&nbsp;&nbsp; Medtronic plc

8.4&nbsp;&nbsp;&nbsp; Tandem Diabetes Care

8.5&nbsp;&nbsp;&nbsp; Sanofi

8.6&nbsp;&nbsp;&nbsp; Biocon

8.7&nbsp;&nbsp;&nbsp; Eli Lilly &amp; Company

8.8&nbsp;&nbsp;&nbsp; Insulet Corporation

8.9&nbsp;&nbsp;&nbsp; Roche

8.10&nbsp;&nbsp;&nbsp; B Braun Melsungen AG

8.11&nbsp;&nbsp;&nbsp; Microport

8.12&nbsp;&nbsp;&nbsp; Medtrum Technologies

8.13&nbsp;&nbsp;&nbsp; Arkray

8.14&nbsp;&nbsp;&nbsp; A. Menarini Diagnostics

8.15&nbsp;&nbsp;&nbsp; Terumo Corporation

8.16&nbsp;&nbsp;&nbsp; Nipro Corporation

8.17&nbsp;&nbsp;&nbsp; KDL Medical

8.18&nbsp;&nbsp;&nbsp; KDL Medical

8.19&nbsp;&nbsp;&nbsp; Zealand Pharma

8.20&nbsp;&nbsp;&nbsp; ViCentra B.V.

8.21&nbsp;&nbsp;&nbsp; Julphar Pharmaceuticals

&nbsp;&nbsp;&nbsp;

Insulin Delivery Devices Market

Customize This Report

Industries

Information

Link

Global Headquarters